Latest guidance given with Q3 FY2026 results, 27 Oct 2026
| Measure | Period | Guidance | As stated |
|---|---|---|---|
| EPS | Q4 FY2026 | $2.25 to $2.31 | Diluted EPS is projected to be between $2.25 and $2.31. |
| EBITDA · Adjusted | Q4 FY2026 | $1.05B to $1.07B | Adjusted EBITDA is projected to be between $1,047 million and $1,067 million. |
| Net income | Q4 FY2026 | $508M to $522M | Net income is projected to be between $508 million and $522 million. |
| RevPAR growth | Q4 FY2026 | +3% to +3.5% | System-wide comparable RevPAR, on a currency neutral basis, is projected to increase between 3.0 percent and 3.5 percent compared to the fourth quarter of 2025. |
| EBITDA · Adjusted | FY2026 | $4.06B to $4.08B | Full year 2026 system-wide RevPAR is projected to increase between 4.0 percent and 4.5 percent on a comparable and currency neutral basis compared to 2025; full year net income is projected to be between $1,909 million and $1,923 million; full year Adjusted EBITDA is projected to be between $4,060 million and $4,080 million |
| Net income | FY2026 | $1.91B to $1.92B | Full year 2026 system-wide RevPAR is projected to increase between 4.0 percent and 4.5 percent on a comparable and currency neutral basis compared to 2025; full year net income is projected to be between $1,909 million and $1,923 million; full year Adjusted EBITDA is projected to be between $4,060 million and $4,080 million |
| RevPAR growth | FY2026 | +4% to +4.5% | Full year 2026 system-wide RevPAR is projected to increase between 4.0 percent and 4.5 percent on a comparable and currency neutral basis compared to 2025; full year net income is projected to be between $1,909 million and $1,923 million; full year Adjusted EBITDA is projected to be between $4,060 million and $4,080 million |
Source: the company's earnings release.
